Condition
Cardiac Pacemaker
Total Trials
10
Recruiting
6
Active
8
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
10.0%
1 terminated out of 10 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
20%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Recruiting6
Active Not Recruiting2
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (10)
Showing 10 of 10 trials
NCT07287423Not ApplicableRecruitingPrimary
LEAP 2 Chronic EFS
NCT07393009Recruiting
BIO|STREAM.CSP Study
NCT05270499Active Not RecruitingPrimary
Aveir VR Real-World Evidence Post-Approval Study
NCT05935007RecruitingPrimary
Aveir DR Real-World Evidence Post-Approval Study
NCT05498376Phase 4Active Not RecruitingPrimary
The Leadless AV Versus DDD Pacing Study
NCT05336877RecruitingPrimary
Aveir VR Coverage With Evidence Development Post-Approval Study
NCT06542133CompletedPrimary
AVEIR Remote Care System Non-Significant Risk Study
NCT05932602RecruitingPrimary
AVEIR DR Coverage With Evidence Development (CED) Study
NCT06100770RecruitingPrimary
Aveir AR Coverage With Evidence Development (CED) Study
NCT02195024Phase 4Terminated
Cardiac MRI After Pacemaker Replacement
Showing all 10 trials